Home > NRC Library > ADAMS Public Documents

Forwards Amend 2 to Final Design Approval FDA-1 for BWR/6 Nuclear Island design (GESSAR-II) & notice of issuance of amend.Amend removes constraints on issuing CPs & OLs to applicants ref GESSAR-II design.

Accession Number: ML20210J400

Date Released: Tuesday, August 11, 2020

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML20210J396 - Forwards Amend 2 to Final Design Approval FDA-1 for BWR/6 Nuclear Island design (GESSAR-II) & notice of issuance of amend.Amend removes constraints on issuing CPs & OLs to applicants ref GESSAR-II design. (3 page(s), 9/22/1986)
• ML20210J464 - Amend 2 to Final Design Approval FDA-1 for GESSAR-II BWR/6 Nuclear Island design.Amend removes constraints on issuing CPs & OLs to applicants ref GESSAR-II design. (4 page(s), 9/22/1986)
• ML20210J534 - Notice of issuance of Amend 2 to Final Design Approval FDA-1 for GESSAR-II BWR/6 Nuclear Island design.Amend 2 allows issuance of CPs or OLs to applicants ref GESSAR-II design. (4 page(s), 9/22/1986)